产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 98% 询价
- +
5mg 98% 询价
- +
10mg 98% 询价
- +
25mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

2361659-61-0

中文名称

AES-135

英文名称

AES-135

别名

Benzamide, 4-[[[4-(1,1-dimethylethyl)phenyl]methyl][2-[[(4-fluorophenyl)sulfonyl][(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxy-;AES135,HDAC,HDAC3,HDAC11,pancreatic,HDAC6,anti-tumor,Inhibitor,AES 135,Histone deacetylases,inhibit,AES-135;AES-135, 10 mM in DMSO

标准英文名

4-(N-(4-(tert-butyl)benzyl)-2-((4-fluoro-N-((perfluorophenyl)methyl)phenyl)sulfonamido)acetamido)-N-hydroxybenzamide

MDL No.

MFCD31813798

分子式

C33H29F6N3O5S

分子量

693.67

精确分子量

693.17

SMILES

CC(C)(C1=CC=C(C=C1)CN(C2=CC=C(C=C2)C(NO)=O)C(CN(S(=O)(C3=CC=C(C=C3)F)=O)CC4=C(C(F)=C(C(F)=C4F)F)F)=O)C

标准SMILES

CC(C)(C)C1C=CC(CN(C2C=CC(=CC=2)C(=O)NO)C(=O)CN(CC2C(F)=C(F)C(F)=C(F)C=2F)S(=O)(=O)C2C=CC(F)=CC=2)=CC=1

用途

AES-135 is a hydroxamic acid-based histone deacetylase (HDAC) inhibitor with anti-tumor activity, specifically inhibiting HDAC3, HDAC6, HDAC8, and HDAC11 (IC50 = 190–1100 nM). It demonstrates potent in vitro anti-proliferative effects against various cancer cell lines, including pancreatic, leukemia, breast, and prostate cancer cells. In vivo, AES-135 significantly prolongs survival in orthotopic pancreatic cancer mouse models (e.g., C57Bl/6 mice implanted with KPC2 cells) when administered intraperitoneally at 50 mg/kg, five days per week for one month. It exhibits favorable pharmacokinetics in mice, achieving micromolar blood concentrations with a half-life of 5.0 hours, supporting its potential as a therapeutic agent for cancer treatment.

InChIKey

LTRKEOBJRDKIHB-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  2361659-61-0 逆合成路线 1

—
—
—
—
ACWOMS759
2361659-61-0
来源: SureRoute

2.  2361659-61-0 逆合成路线 2

—
—
ACWOMS759
2361659-61-0
来源: SureRoute

3.  2361659-61-0 逆合成路线 3

—
—
—
—
ACWOMS759
2361659-61-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手